Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 39 min ago
Peer-reviewedCC BY-NC-NDAnnals of the rheumatic diseases

Spatially Distinct Macrophage Subsets Drive Myofibroblast Heterogeneity and Maladaptive Fibrosis in Lupus Nephritis

4 affiliations
  1. 1The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA
  2. 2Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
  3. 3University of Chicago, Chicago, Illinois, USA
  4. 4Broad Institute of MIT and Harvard, Cambridge, MA, USA

Abstract

OBJECTIVES: Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE), leading to progressive renal fibrosis and functional decline. Understanding the interplay between immune cells and stromal cells is needed to develop effective therapeutic strategies. In this study, we investigated the landscape of macrophage-fibroblast interactions in human LN and validated these findings in mouse models. METHODS: We characterised distinct fibroblast subsets and their interactions with renal macrophages using single-cell RNA sequencing of 156 human LN biopsies and 30 healthy controls from the Accelerating Medicines Partnership-SLE cohort, and spatial transcriptomics of biopsies from 6 patients with LN. In vitro coculture studies using mouse models were performed to further define functional consequences of these interactions. RESULTS: We identified 2 myofibroblast subsets: a proinflammatory subset (Myofib1) enriched in the tubulointerstitium, and a fibrotic/remodelling subset (Myofib2) in glomeruli, both correlating with the histologic chronicity index. Spatial transcriptomics revealed different colocalisation patterns, with Myofib1 interacting with activated resident macrophage (RM) subsets and Myofib2 with glomerular infiltrating disease-associated macrophages. In vitro coculture studies demonstrated that nephritic RMs promote a proinflammatory, remodelling fibroblast phenotype that impairs wound healing and drives a Myofib1-like gene programme, whereas disease-associated macrophages generated profibrotic fibroblasts with dysregulated reparative capacity. Cell-cell communication analyses identified key ligand-receptor interactions mediating this crosstalk, including Spp1/integrins, Sema4/PlexinB, and nicotinamide phosphoribosyl transferase/INSR. CONCLUSIONS: Our data reveal a spatially and functionally heterogeneous landscape of macrophage-fibroblast crosstalk in LN. These findings advance our understanding of renal fibrogenesis in LN, highlighting specific fibroinflammatory circuits that may represent therapeutic targets to prevent chronic renal damage.

Related

  1. The role and mechanism of macrophage-to-myofibroblast transition in fibrotic diseases
    Hua Guo, Xiao Xiao Tang
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textCardiovascular medicineCrossrefEurope PMC
  2. Identification of a spatially organized TREM2-associated permissive macrophage niche in human pulmonary tuberculosis alveolar pneumonia.
    Rosane M B Teles, Chaouki Benabdessalem, Jonathan Perrie +30
    Nature communicationsPeer-reviewedCC BYFull textInfectious diseaseEurope PMC
  3. Mapping intestinal microenvironment heterogeneity in Hirschsprung's disease by spatial transcriptomics: Role of THBS1 in macrophage polarization and neural stem cell regulation.
    Jinxin Li, Junbao Du, Lian Hou +2
    Genes & diseasesPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  4. Spatially dissecting drivers of inter- and intra-tumoral heterogeneity in Kenyan breast cancer.
    Mustapha Abubakar, Shahin Sayed, Hela Koka +20
    Breast cancer research : BCRPeer-reviewedCC BYFull textOncologyEurope PMCDOAJ
  5. Single-cell heterogeneity of adipose eosinophils is shaped by sex and RELMα and linked to macrophage communication networks in obesity
    Rebecca E Ruggiero-Ruff, Xinru Qiu, Lauren Vance +4
    PNAS NexusPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMC
BibTeX
@article{raparia2026spatially,
  title = {{Spatially Distinct Macrophage Subsets Drive Myofibroblast Heterogeneity and Maladaptive Fibrosis in Lupus Nephritis}},
  author = {Chirag Raparia and Paul Hoover and Junting Ai and Marcus Clark and Sujal Shah and the Accelerating Medicines Partnership (AMP): RA/SLE Network and Betty Diamond and Nir Hacohen and Arnon Arazi and Anne Davidson},
  journal = {Annals of the rheumatic diseases},
  year = {2026},
  month = aug,
  doi = {10.1016/j.ard.2026.07.014},
  url = {https://doi.org/10.1016/j.ard.2026.07.014},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Spatially Distinct Macrophage Subsets Drive Myofibroblast Heterogeneity and Maladaptive Fibrosis in Lupus Nephritis
AU  - Chirag Raparia
AU  - Paul Hoover
AU  - Junting Ai
AU  - Marcus Clark
AU  - Sujal Shah
AU  - the Accelerating Medicines Partnership (AMP): RA/SLE Network
AU  - Betty Diamond
AU  - Nir Hacohen
AU  - Arnon Arazi
AU  - Anne Davidson
PY  - 2026
DA  - 2026/08/13
JO  - Annals of the rheumatic diseases
DO  - 10.1016/j.ard.2026.07.014
UR  - https://doi.org/10.1016/j.ard.2026.07.014
AB  - OBJECTIVES: Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE), leading to progressive renal fibrosis and functional decline. Understanding the interplay between immune cells and stromal cells is needed to develop effective therapeutic strategies. In this study, we investigated the landscape of macrophage-fibroblast interactions in human LN and validated these findings in mouse models. METHODS: We characterised distinct fibroblast subsets and their interactions with renal macrophages using single-cell RNA sequencing of 156 human LN biopsies and 30 healthy controls from the Accelerating Medicines Partnership-SLE cohort, and spatial transcriptomics of biopsies from 6 patients with LN. In vitro coculture studies using mouse models were performed to further define functional consequences of these interactions. RESULTS: We identified 2 myofibroblast subsets: a proinflammatory subset (Myofib1) enriched in the tubulointerstitium, and a fibrotic/remodelling subset (Myofib2) in glomeruli, both correlating with the histologic chronicity index. Spatial transcriptomics revealed different colocalisation patterns, with Myofib1 interacting with activated resident macrophage (RM) subsets and Myofib2 with glomerular infiltrating disease-associated macrophages. In vitro coculture studies demonstrated that nephritic RMs promote a proinflammatory, remodelling fibroblast phenotype that impairs wound healing and drives a Myofib1-like gene programme, whereas disease-associated macrophages generated profibrotic fibroblasts with dysregulated reparative capacity. Cell-cell communication analyses identified key ligand-receptor interactions mediating this crosstalk, including Spp1/integrins, Sema4/PlexinB, and nicotinamide phosphoribosyl transferase/INSR. CONCLUSIONS: Our data reveal a spatially and functionally heterogeneous landscape of macrophage-fibroblast crosstalk in LN. These findings advance our understanding of renal fibrogenesis in LN, highlighting specific fibroinflammatory circuits that may represent therapeutic targets to prevent chronic renal damage.
SN  - 0003-4967
SN  - 1468-2060
ER  -